Pathogenesis of Pneumococcal Meningitis

Joerg R. Weber

doi:10.1128/9781555816537.ch16

Chapter 16 : Pathogenesis of Pneumococcal Meningitis

Author: Joerg R. Weber¹

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Department of Neurology, Charité, Universitätsmedizin Berlin, D-10098 Berlin, Germany

Content Type: Monograph

Publication Year: 2004

Category: Bacterial Pathogenesis; Clinical Microbiology

Book DOI: 10.1128/9781555816537

Chapter DOI: 10.1128/9781555816537.ch16

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Pathogenesis of Pneumococcal Meningitis, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555816537/9781555812973_Chap16-1.gif /docserver/preview/fulltext/10.1128/9781555816537/9781555812973_Chap16-2.gif

Abstract:

Pneumococcal meningitis is still an unresolved problem in clinical medicine. A number of recent studies demonstrate the unfavorable outcome of pneumococcal meningitis, reporting mortality rates up to 40%. Most models are based on the injection of pneumococci or their inflammatory components into the subarachnoidal space, followed by the hallmarks of meningitis: the influx of leukocytes into CSF, development of brain edema, intracranial pressure, and typical histological changes. Inhibition of TNF-α results in decreased leukocyte invasion in pneumococcal meningitis. Deficiency in interleukin-18 (IL-18), another cytokine cleaved by caspase-1, results in reduced inflammation and better survival in experimental pneumococcal meningitis. In pneumococcal meningitis, all these steps happen in the arachnoidal microvessels and the triggers for leukocyte-endothelium interactions include histamine and cytokines. In an infant rat model of pneumococcal meningitis, Matrix metalloprotease (MMP) inhibitors decreased inflammatory alterations, including neuronal damage. Different antioxidative strategies interfering with generation of reactive oxygen species attenuate intracranial complications, including neuronal damage in pneumococcal meningitis in the adult as well as in the infant animal model. Inhibition of inducible nitric oxide synthase (NOS) ameliorates inflammation in pneumococcal meningitis. In the rabbit model, apoptosis is a predominant mechanism of neuronal damage and focuses on the dentate gyrus. Hippocampal neurons of patients who have died from pneumococcal meningitis show the morphological criteria of apoptosis and active caspase-3. Although the beneficial effect of dexamethasone has been shown in clinical trials, it should be considered that, at least in experimental models, this drug augments apoptosis in the dentate gyrus.

Citation: Weber J. 2004. Pathogenesis of Pneumococcal Meningitis, p 238-251. In Tuomanen E, Mitchell T, Morrison D, Spratt B (ed), The Pneumococcus. ASM Press, Washington, DC. doi: 10.1128/9781555816537.ch16

Highlighted Text: Show | Hide

Full text loading...

Figures

Pathogenesis of Pneumococcal Meningitis

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816537.chap16-1,webId=/content/author/10.1128/9781555816537.chap16-1,properties={foaf_givenname=Joerg R., foaf_name=Joerg R. Weber, foaf_surname=Weber, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816537.chap16-aff1]]}]]

/content/10.1128/9781555816537.chap16.fig16-1

FIGURE 1

Schematic anatomy of the blood-brain barrier. (A) Cerebral vessels mark the blood-brain barrier as formed by tight junctions and supporting cells. (B) In detail, the barrier at the choroid plexus is formed at the layer of epithelial CSF secreting cells that overlay fenestrated endothelial cells. Translocated bacteria are indicated as small ovals. (C) The barrier at the cerebral capillary is formed by tight junctions between endothelial cells that are supported by astrocytes. Translocated bacteria are indicated as small ovals.

10.1128/9781555816537/fig16-1_thmb.gif

10.1128/9781555816537/fig16-1.gif

FIGURE 1

/content/10.1128/9781555816537.chap16.fig16-2

FIGURE 2

Autocrine loop enhancing transmigration of pneumococci across the blood-brain barrier. Pneumococcal cell wall (PCW) induces endothelial cells to produce TNF and NO. These in turn further activate the neighboring cells to produce more NO and up-regulate the PAF receptor (PAFr) and ICAM-1. PAF receptor enables bacterial translocation into the CSF, while ICAM-1 recruits leukocytes.

10.1128/9781555816537/fig16-2_thmb.gif

10.1128/9781555816537/fig16-2.gif

FIGURE 2

/content/10.1128/9781555816537.chap16.fig16-3

FIGURE 3

Schematic of two pathways of neuronal injury in pneumococcal meningitis. ICP, intracranial pressure; ROS, reactive oxygen species; RNI, reactive nitrogen intermediates.

10.1128/9781555816537/fig16-3_thmb.gif

10.1128/9781555816537/fig16-3.gif

FIGURE 3

Schematic of two pathways of neuronal injury in pneumococcal meningitis. ICP, intracranial pressure; ROS, reactive oxygen species; RNI, reactive nitrogen intermediates.

References

/content/book/10.1128/9781555816537.chap16

1. Angstwurm, K.,, D. Freyer,, U. Dirnagl,, U. K. Hanisch,, R. R. Schumann,, K. M. Einhäupl,, and J. R. Weber. 1998. Tumour necrosis factor alpha induces only minor inflammatory changes in the central nervous system, but augments experimental meningitis. Neuroscience 86: 627– 634.

2. Auer, M.,, L. A. Pfister,, D. Leppert,, M. G. Tauber,, and S. L. Leib. 2000. Effects of clinically used antioxidants in experimental pneumococcal meningitis. J. Infect. Dis. 182: 347– 350.

3. Berg, S.,, B. Trollfors,, B. A. Claesson,, K. Alestig,, L. Gothefors,, S. Hugosson,, L. Lindquist,, P. Olcen,, V. Romanus,, and K. Strangert. 1996. Incidence and prognosis of meningitis due to Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis in Sweden. Scand. J. Infect. Dis. 28: 247– 252.

4. Bhatt, S. M.,, A. Lauretano,, C. Cabellos,, C. Halpin,, R. A. Levine,, W. Z. Xu,, J. B. Nadol, Jr., and E. Tuomanen. 1993. Progression of hearing loss in experimental pneumococcal meningitis: correlation with cerebrospinal fluid cytochemistry. J. Infect. Dis. 167: 675– 683.

5. Bohr, V.,, O. B. Paulson,, and N. Rasmussen. 1984. Pneumococcal meningitis. Late neurologic sequelae and features of prognostic impact. Arch. Neurol. 41: 1045– 1049.

6. Braun, J. S.,, R. Novak,, K. H. Herzog,, S. M. Bodner,, J. L. Cleveland,, and E. I. Tuomanen. 1999. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat. Med. 5: 298– 302.

7. Braun, J. S.,, R. Novak,, P. J. Murray,, C. M. Eischen,, S. A. Susin,, G. Kroemer,, A. Halle,, J. R. Weber,, E. I. Tuomanen,, and J. L. Cleveland. 2001. Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J. Infect. Dis. 184: 1300– 1309.

8. Braun, J. S.,, J. E. Sublett,, D. Freyer,, T. J. Mitchell,, J. L. Cleveland,, E. I. Tuomanen,, and J. R. Weber. 2002. Pneumococcal pneumolysin and H 2O2 mediate brain cell apoptosis during meningitis. J. Clin. Investig. 109: 19– 27.

9. Cauwels, A.,, K. Frei,, S. Sansano,, C. Fearns,, R. Ulevitch,, W. Zimmerli,, and R. Landmann. 1999. The origin and function of soluble CD14 in experimental bacterial meningitis. J. Immunol. 162: 4762– 4772.

10. Cauwels, A.,, E. Wan,, M. Leismann,, and E. Tuomanen. 1997. Coexistence of CD14-dependent and independent pathways for stimulation of human monocytes by gram-positive bacteria. Infect. Immun. 65: 3255– 3260.

11. Cleveland, M. G.,, J. D. Gorham,, T. L. Murphy,, E. Tuomanen,, and K. M. Murphy. 1996. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect. Immun. 64: 1906– 1912.

12. Cundell, D. R.,, N. P. Gerard,, C. Gerard,, I. Idanpaan-Heikkila,, and E. I. Tuomanen. 1995. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377: 435– 438.

13. Dacey, R. G.,, and M. A. Sande. 1974. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob. Agents Chemother. 6: 437– 441.

14. Daum, R. S.,, D. W. Scheifele,, V. P. Syriopoulou,, D. Averill,, and A. L. Smith. 1978. Ventricular involvement in experimental Hemophilus influenzae meningitis. J. Pediatr. 93: 927– 930.

15. de Gans, J.,, and D. van de Beek. 2002. Dexamethasone in adults with bacterial meningitis. N. Engl. J. Med. 347: 1549– 1556.

16. Doern, G. V.,, K. P. Heilmann,, H. K. Huynh,, P. R. Rhomberg,, S. L. Coffman,, and A. B. Brueggemann. 2001. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother. 45: 1721– 1729.

17. Dumont, R. A.,, B. D. Car,, N. N. Voitenok,, U. Junker,, B. Moser,, O. Zak,, and T. O’Reilly. 2000. Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits. Infect. Immun. 68: 5756– 5763.

18. Durand, M. L.,, S. B. Calderwood,, D. J. Weber,, S. I. Miller,, F. S. Southwick,, V. S. Caviness, Jr., and M. N. Swartz. 1993. Acute bacterial meningitis in adults. A review of 493 episodes. N. Engl. J. Med. 328: 21– 28.

19. Echchannaoui, H.,, K. Frei,, C. Schnell,, S. L. Leib,, W. Zimmerli,, and R. Landmann. 2002. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis. 186: 798– 806.

20. Fiore, A. E.,, J. F. Moroney,, M. M. Farley,, L. H. Harrison,, J. E. Patterson,, J. H. Jorgensen,, M. Cetron,, M. S. Kolczak,, R. F. Breiman,, and A. Schuchat. 2000. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin. Infect. Dis. 30: 71– 77.

21. Fraser, D. W.,, C. P. Darby,, R. E. Koehler,, C. F. Jacobs,, and R. A. Feldman. 1973. Risk factors in bacterial meningitis: Charleston County, South Carolina. J. Infect. Dis. 127: 271– 277.

22. Free, S. L.,, L. M. Li,, D. R. Fish,, S. D. Shorvon,, and J. M. Stevens. 1996. Bilateral hippocampal volume loss in patients with a history of encephalitis or meningitis. Epilepsia 37: 400– 405.

23. Freyer, D.,, R. Manz,, A. Ziegenhorn,, M. Weih,, K. Angstwurm,, W. D. Docke,, A. Meisel,, R. R. Schumann,, G. Schonfelder,, U. Dirnagl,, and J. R. Weber. 1999. Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J. Immunol. 163: 4308– 4314.

24. Gerber, J.,, G. Raivich,, A. Wellmer,, C. Noeske,, T. Kunst,, A. Werner,, W. Bruck,, and R. Nau. 2001. A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease. Acta Neuropathol. 101: 499– 508.

25. Gloor, S. M.,, M. Wachtel,, M. F. Bolliger,, H. Ishihara,, R. Landmann,, and K. Frei. 2001. Molecular and cellular permeability control at the blood-brain barrier. Brain Res. Rev. 36: 258– 264.

26. Hanisch, U. K.,, M. Prinz,, K. Angstwurm,, K. G. Hausler,, O. Kann,, H. Kettenmann,, and J. R. Weber. 2001. The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls. Eur. J. Immunol. 31: 2104– 2115.

27. Hasbun, R.,, J. Abrahams,, J. Jekel,, and V. J. Quagliarello. 2001. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N. Engl. J. Med. 345: 1727– 1733.

28. Hausler, K. G.,, M. Prinz,, C. Nolte,, J. R. Weber,, R. R. Schumann,, H. Kettenmann,, and U. K. Hanisch. 2002. Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur. J. Neurosci. 16: 2113– 2122.

29. Hirst, R. A.,, B. Gosai,, A. Rutman,, P. W. Andrew,, and C. O’Callaghan. 2003. Streptococcus pneumoniae damages the ciliated ependyma of the brain during meningitis. Infect. Immun. 71: 6095– 6100.

30. Hirst, R. A.,, K. S. Sikand,, A. Rutman,, T. J. Mitchell,, P. W. Andrew,, and C. O’Callaghan. 2000. Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency. Infect. Immun. 68: 1557– 1562.

31. Hoffmann, O.,, N. Keilwerth,, M. B. Bille,, U. Reuter,, K. Angstwurm,, R. R. Schumann,, U. Dirnagl,, and J. R. Weber. 2002. Triptans reduce the inflammatory response in bacterial meningitis. J. Cereb. Blood Flow Metab. 22: 988– 996.

32. Kastenbauer, S.,, U. Koedel,, B. F. Becker,, and H. W. Pfister. 2002. Oxidative stress in bacterial meningitis in humans. Neurology 58: 186– 191.

33. Kastenbauer, S.,, U. Koedel,, and H. W. Pfister. 1999. Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. J. Infect. Dis. 180: 1164– 1170.

34. Kastenbauer, S.,, and H. W. Pfister. 2003. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 126: 1015– 1025.

35. Kaufmann, A. F.,, and K. D. Quist. 1969. Pneumococcal meningitis and peritonitis in rhesus monkeys. J. Am. Vet. Med. Assoc. 155: 1158– 1162.

36. Kim, J. O.,, and J. N. Weiser. 1998. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis. 177: 368– 377.

37. Koedel, U.,, B. Angele,, T. Rupprecht,, H. Wagner,, A. Roggenkamp,, H. W. Pfister,, and C. J. Kirschning. 2003. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol. 170: 438– 444.

38. Koedel, U.,, I. Bayerlein,, R. Paul,, B. Sporer,, and H. W. Pfister. 2000. Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental pneumococcal meningitis. J. Infect. Dis. 182: 1437– 1445.

39. Koedel, U.,, A. Bernatowicz,, K. Frei,, A. Fontana,, and H. W. Pfister. 1996. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J. Immunol. 157: 5185– 5191.

40. Koedel, U.,, A. Bernatowitz,, R. Paul,, K. Frei,, A. Fontana,, and H. W. Pfister. 1995. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann. Neurol. 37: 313– 323.

41. Koedel, U.,, R. Paul,, F. Winkler,, S. Kastenbauer,, P. L. Huang,, and H. W. Pfister. 2001. Lack of endothelial nitric oxide synthase aggravates murine pneumococcal meningitis. J. Neuropathol. Exp. Neurol. 60: 1041– 1050.

42. Koedel, U.,, F. Winkler,, B. Angele,, A. Fontana,, R. A. Flavell,, and H. W. Pfister. 2002. Role of caspase-1 in experimental pneumococcal meningitis: evidence from pharmacologic caspase inhibition and caspase-1-deficient mice. Ann. Neurol. 51: 319– 329.

43. Leib, S. L.,, J. M. Clements,, R. L. Lindberg,, C. Heimgartner,, J. M. Loeffler,, L. A. Pfister,, M. G. Tauber,, and D. Leppert. 2001. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 124: 1734– 1742.

44. Leib, S. L.,, C. Heimgartner,, Y. D. Bifrare,, J. M. Loeffler,, and M. G. Tauber. 2003. Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr. Res. 54: 353– 357.

45. Leib, S. L.,, Y. S. Kim,, L. L. Chow,, R. A. Sheldon,, and M. G. Tauber. 1996. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J. Clin. Investig. 98: 2632– 2639.

46. Leib, S. L.,, D. Leppert,, J. Clements,, and M. G. Tauber. 2000. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect. Immun. 68: 615– 620.

47. Leppert, D.,, S. L. Leib,, C. Grygar,, K. M. Miller,, U. B. Schaad,, and G. A. Hollander. 2000. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin. Infect. Dis. 31: 80– 84.

48. Loeffler, J. M.,, R. Ringer,, M. Hablutzel,, M. G. Tauber,, and S. L. Leib. 2001. The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. J. Infect. Dis. 183: 247– 252.

48.a. Lorenzl, S.,, U. Koedel,, U. Dirnagl,, G. Ruckdeschel,, and H. W. Pfisten. 1993. Imaging of leukocyte-endothelium interaction using in vivo confocal laser scanning microscopy during the early phase of experimental pneumococcal meningitis. J. Infect. Dis. 168: 927– 933.

49. Malley, R.,, P. Henneke,, S. C. Morse,, M. J. Cieslewicz,, M. Lipsitch,, C. M. Thompson,, E. Kurt-Jones,, J. C. Paton,, M. R. Wessels,, and D. T. Golenbock. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA 100: 1966– 1971.

50. Marra, A.,, and D. Brigham. 2001. Streptococcus pneumoniae causes experimental meningitis following intranasal and otitis media infections via a nonhematogenous route. Infect. Immun. 69: 7318– 7325.

51. McCullers, J. A.,, B. K. English,, and R. Novak. 2000. Isolation and characterization of vancomycin- tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J. Infect. Dis. 181: 369– 373.

52. Merkelbach, S.,, H. Sittinger,, I. Schweizer,, and M. Müller. 2000. Cognitive outcome after bacterial meningitis. Acta Neurol. Scand. 102: 118– 123.

53. Mitchell, T. J. 2000. Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae. Res. Microbiol. 151: 413– 419.

54. Molyneux, E. M.,, A. L. Walsh,, H. Forsyth,, M. Tembo,, J. Mwenechanya,, K. Kayira,, L. Bwanaisa,, A. Njobvu,, S. Rogerson,, and G. Malenga. 2002. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 360: 211– 218.

55. Monier, R. M.,, K. L. Orman,, E. A. Meals,, and B. K. English. 2002. Differential effects of p38- and extracellular signal-regulated kinase mitogen-activated protein kinase inhibitors on inducible nitric oxide synthase and tumor necrosis factor production in murine macrophages stimulated with Streptococcus pneumoniae. J. Infect. Dis. 185: 921– 926.

56. Nau, R.,, A. Soto,, and W. Bruck. 1999. Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J. Neuropathol. Exp. Neurol. 58: 265– 274.

57. O’Dempsey, T. J.,, T. F. McArdle,, N. Lloyd-Evans,, I. Baldeh,, B. E. Lawrence,, O. Secka,, and B. Greenwood. 1996. Pneumococcal disease among children in a rural area of west Africa. Pediatr. Infect. Dis. J. 15: 431– 437.

58. Oggioni, M. R.,, G. Memmi,, T. Maggi,, D. Chiavolini,, F. Iannelli,, and G. Pozzi. 2003. Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Mol. Microbiol. 49: 795– 805.

59. Paul, R.,, U. Koedel,, F. Winkler,, B. C. Kieseier,, A. Fontana,, M. Kopf,, H. P. Hartung,, and H. W. Pfister. 2003. Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain 126: 1873– 1882.

60. Pfister, H. W.,, K. Frei,, B. Ottnad,, U. Koedel,, A. Tomasz,, and A. Fontana. 1992. Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis. J. Exp. Med. 176: 265– 268.

61. Pfister, H. W.,, U. Ködel,, U. Dirnagl,, R. L. Haberl,, G. Ruckdeschel,, and K. M. Einhäupl. 1992. Effect of catalase on regional cerebral blood flow and brain edema during the early phase of experimental pneumococcal meningitis. J. Infect. Dis. 166: 1442– 1445.

62. Pfister, H. W.,, U. Koedel,, R. L. Haberl,, U. Dirnagl,, W. Feiden,, G. Ruckdeschel,, and K. Einhäupl. 1990. Microvascular changes during the early phase of experimental bacterial meningitis. J. Cereb. Blood Flow Metab. 10: 914– 922.

63. Polfliet, M. M.,, P. J. Zwijnenburg,, A. M. van Furth,, T. van der Poll,, E. A. Dopp,, C. Renar del de Lavalette,, E. M. van Kesteren-Hendrikx,, N. van Rooijen,, C. D. Dijkstra,, and T. K. van den Berg. 2001. Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis. J. Immunol. 167: 4644– 4650.

64. Pron, B.,, M. K. Taha,, C. Rambaud,, J. C. Fournet,, N. Pattey,, J. P. Monnet,, M. Musilek,, J. L. Beretti,, and X. Nassif. 1997. Interaction of Neisseria meningitidis with the components of the blood-brain barrier correlates with an increased expression of PilC. J. Infect. Dis. 176: 1285– 1292.

65. Quagliarello, V. J.,, W. J. Long,, and W. M. Scheld. 1986. Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation. J. Clin. Investig. 77: 1084– 1095.

66. Richter, S. S.,, K. P. Heilmann,, S. L. Coffman,, H. K. Huynh,, A. B. Brueggemann,, M. A. Pfaller,, and G. V. Doern. 2002. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. Clin. Infect. Dis. 34: 330– 339.

67. Ring, A.,, J. N. Weiser,, and E. I. Tuomanen. 1998. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J. Clin. Investig. 102: 347– 360.

68. Rodriguez, A. F.,, S. L. Kaplan,, E. P. Hawkins,, and E. O. Mason, Jr. 1991. Hematogenous pneumococcal meningitis in the infant rat: description of a model. J. Infect. Dis. 164: 1207– 1209.

69. Rosenow, C.,, P. Ryan,, J. N. Weiser,, S. Johnson,, P. Fontan,, A. Ortqvist,, and H. R. Masure. 1997. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25: 819– 829.

70. Rossi, D.,, and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217– 242.

71. Saukkonen, K.,, S. Sande,, C. Cioffe,, S. Wolpe,, B. Sherry,, A. Cerami,, and E. Tuomanen. 1990. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J. Exp. Med. 171: 439– 448.

72. Schroder, N. W.,, S. Morath,, C. Alexander,, L. Hamann,, T. Hartung,, U. Zahringer,, U. B. Gobel,, J. R. Weber,, and R. R. Schumann. 2003. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278: 15587– 15594.

73. Schuchat, A.,, K. Robinson,, J. D. Wenger,, L. H. Harrison,, M. Farley,, A. L. Reingold,, L. Lefkowitz,, and B. A. Perkins. 1997. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 337: 970– 976.

74. Schumann, R. R.,, D. Pfeil,, W. Bürger,, N. Lamping,, C. J. Kirschning,, U. Goebel,, and J. R. Weber. 1998. Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p 38 in astrocytes. Glia 22: 295– 305.

75. Segal, M. B. 2000. The choroid plexuses and the barriers between the blood and the cerebrospinal fluid. Cell. Mol. Neurobiol. 20: 183– 196.

76. Simberkoff, M. S.,, N. H. Moldover,, and J. Rahal, Jr. 1980. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency. J. Lab. Clin. Med. 95: 362– 372.

77. Spanaus, K. S.,, D. Nadal,, H. W. Pfister,, J. Seebach,, U. Widmer,, K. Frei,, S. Gloor,, and A. Fontana. 1997. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J. Immunol. 158: 1956– 1964.

78. Spellerberg, B.,, C. Rosenow,, W. Sha,, and E. I. Tuomanen. 1996. Pneumococcal cell wall activates NF-kappa B in human monocytes: aspects distinct from endotoxin. Microb. Pathog. 20: 309– 317.

79. Stanek, R. J.,, and M. A. Mufson. 1999. A 20-year epidemiological study of pneumococcal meningitis. Clin. Infect. Dis. 28: 1265– 1272.

80. Strazielle, N.,, and J. F. Ghersi-Egea. 2000. Choroid plexus in the central nervous system: biology and physiopathology. J. Neuropathol. Exp. Neurol. 59: 561– 574.

81. Tauber, M. G.,, and B. Moser. 1999. Cytokines and chemokines in meningeal inflammation: biology and clinical implications. Clin. Infect. Dis. 28: 1– 11.

82. Tuomanen, E.,, H. Liu,, B. Hengstler,, O. Zak,, and A. Tomasz. 1985. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151: 859– 868.

83. Tuomanen, E. I.,, K. Saukkonen,, S. Sande,, C. Cioffe,, and S. D. Wright. 1989. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J. Exp. Med. 170: 959– 969.

84. van de Beek, D.,, B. Schmand,, J. de Gans,, M. Weisfelt,, H. Vaessen,, J. Dankert,, and M. Vermeulen. 2002. Cognitive impairment in adults with good recovery after bacterial meningitis. J. Infect. Dis. 186: 1047– 1052.

85. van Furth, A. M.,, J. J. Roord,, and R. van Furth. 1996. Roles of proinflammatory and antiinflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect. Immun. 64: 4883– 4890.

86. von Mering, M.,, A. Wellmer,, U. Michel,, S. Bunkowski,, A. Tlustochowska,, W. Bruck,, U. Kuhnt,, and R. Nau. 2001. Transcriptional regulation of caspases in experimental pneumococcal meningitis. Brain Pathol. 11: 282– 295.

87. Weber, J. R.,, K. Angstwurm,, W. Bürger,, K. M. Einhäupl,, and U. Dirnagl. 1995. Anti ICAM-1 (CD54) monoclonal antibody reduces inflammatory changes in experimental bacterial meningitis. J. Neuroimmunol. 63: 63– 68.

88. Weber, J. R.,, K. Angstwurm,, D. Freyer,, M. Weih,, C. Busch,, W. Bürger,, and U. Dirnagl. 1996. Heparansulfate and heparin attenuate regional cerebral blood flow (rCBF) increase in experimental bacterial meningitis. Soc. Neurosci. Abstr. 22: 677.

89. Weber, J. R.,, K. Angstwurm,, T. Rosenkranz,, U. Lindauer,, W. Bürger,, K. M. Einhäupl,, and U. Dirnagl. 1997. Histamine (H1) receptor antagonist inhibits leukocyte rolling in pial vessels in the early phase of bacterial meningitis in rats. Neurosci. Lett. 226: 17– 20.

90. Weber, J. R.,, K. Angstwurm,, T. Rosenkranz,, U. Lindauer,, D. Freyer,, W. Burger,, C. Busch,, K. M. Einhaupl,, and U. Dirnagl. 1997. Heparin inhibits leukocyte rolling in pial vessels and attenuates inflammatory changes in a rat model of experimental bacterial meningitis. J. Cereb. Blood Flow Metab. 17: 1221– 1229.

91. Weber, J. R.,, D. Freyer,, C. Alexander,, N. W. Schroder,, A. Reiss,, C. Kuster,, D. Pfeil,, E. I. Tuomanen,, and R. R. Schumann. 2003. Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity 19: 269– 279.

92. Weber, J. R.,, P. Moreillon,, and E. I. Tuomanen. 2003. Innate sensors for Gram-positive bacteria. Curr. Opin. Immunol. 15: 408– 415.

93. Wellmer, A.,, J. Gerber,, J. Ragheb,, G. Zysk,, T. Kunst,, A. Smirnov,, W. Bruck,, and R. Nau. 2001. Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect. Immun. 69: 6881– 6886.

94. Wenger, J. D.,, A. W. Hightower,, R. R. Facklam,, S. Gaventa,, C. V. Broome, and The Bacterial Meningitis Study Group. 1990. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J. Infect. Dis. 162: 1316– 1323.

95. Whitney, C. G.,, M. M. Farley,, J. Hadler,, L. H. Harrison,, N. M. Bennett,, R. Lynfield,, A. Reingold,, P. R. Cieslak,, T. Pilishvili,, D. Jackson,, R. R. Facklam,, J. H. Jorgensen,, and A. Schuchat. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348: 1737– 1746.

96. Whitney, C. G.,, M. M. Farley,, J. Hadler,, L. H. Harrison,, C. Lexau,, A. Reingold,, L. Lefkowitz,, P. R. Cieslak,, M. Cetron,, E. R. Zell,, J. H. Jorgensen,, and A. Schuchat. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343: 1917– 1924.

97. Winkler, F.,, U. Koedel,, S. Kastenbauer,, and H. W. Pfister. 2001. Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown. J. Infect. Dis. 183: 1749– 1759.

98. Yong, V. W.,, C. Power,, P. Forsyth,, and D. R. Edwards. 2001. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2: 502– 511.

99. Yoshimura, A.,, E. Lien,, R. R. Ingalls,, E. Tuomanen,, R. Dziarski,, and D. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163: 1– 5.

100. Zwijnenburg, P. J.,, T. van der Poll,, S. Florquin,, S. Akira,, K. Takeda,, J. J. Roord,, and A. M. van Furth. 2003. Interleukin-18 gene-deficient mice show enhanced defense and reduced inflammation during pneumococcal meningitis. J. Neuroimmunol. 138: 31– 37.

101. Zwijnenburg, P. J.,, T. van der Poll,, S. Florquin,, J. J. Roord,, and A. M. van Furth. 2003. IL-1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis. J. Immunol. 170: 4724– 4730.

102. Zwijnenburg, P. J.,, T. van der Poll,, S. Florquin,, J. J. Roord,, and A. M. van Furth. 2003. Interleukin-10 negatively regulates local cytokine and chemokine production but does not influence antibacterial host defense during murine pneumococcal meningitis. Infect. Immun. 71: 2276– 2279.

103. Zwijnenburg, P. J.,, T. van der Poll,, S. Florquin,, S. J. van Deventer,, J. J. Roord,, and A. M. van Furth. 2001. Experimental pneumococcal meningitis in mice: a model of intranasal infection. J. Infect. Dis. 183: 1143– 1146.

104. Zysk, G.,, W. Bruck,, J. Gerber,, Y. Bruck,, H. W. Prange,, and R. Nau. 1996. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J. Neuropathol. Exp. Neurol. 55: 722– 728.